1. RETRACTED ARTICLE: miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB
    Yuanchang Hu et al, 2018, Cell Death & Disease CrossRef
  2. Hsa-miR-330-5p Aggravates Thyroid Carcinoma via Targeting FOXE1
    Yuxia Wang et al, 2021, Journal of Oncology CrossRef
  3. Promising therapeutic role of miR-27b in tumor
    Li Ding et al, 2017, Tumor Biology CrossRef
  4. MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma
    Lina Cheng et al, 2017, Digestive Diseases and Sciences CrossRef
  5. Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling
    Jingyuan Wen et al, 2022, Cellular & Molecular Biology Letters CrossRef
  6. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development
    Devis Pascut et al, 2021, Cancers CrossRef
  7. microRNA-27b regulates hepatic lipase enzyme LIPC and reduces triglyceride degradation during hepatitis C virus infection
    Geneviève.F. Desrochers et al, 2022, Journal of Biological Chemistry CrossRef
  8. LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma
    Chang Liu et al, 2024, Journal of Biological Chemistry CrossRef
  9. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR‐422a/PDK2 axis
    Feifei Wei et al, 2020, Cancer Medicine CrossRef
  10. Expression and effect of miR‑27b in primary liver cancer
    Lijuan Zhuo et al, 2023, Oncology Letters CrossRef
  11. HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma
    Y J Jia et al, 2018, Leukemia CrossRef